Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses

被引：16

作者：

Godfroid, F ^{[1
]}

Denoël, P ^{[1
]}

de Grave, D ^{[1
]}

Schuerman, L ^{[1
]}

Poolman, J ^{[1
]}

机构：

[1] GlaxoSmithKline Biol, Res & Dev, B-1330 Rixensart, Belgium

来源：

INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY | 2004年 / 294卷 / 05期

关键词：

vaccine combinations; pertussis; immunogenicity; non-inferiority; mouse model;

D O I：

10.1016/j.ijmm.2004.07.007

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Diphtheria-tetanus-pertussis (DTP) combination vaccines based on inactivated whole-cell Bordetella pertussis (DTPw) or purified acellular pertussis components (DTPa) facilitate vaccine administration and will allow further co-administration such as with pneumococcal conjugates. Safety and immunogenicity studies are needed to demonstrate non-inferiority between combinations and the separate vaccines. The immunological non-inferiority is based on threshold antibody levels that represent correlates of protection. However, in case of pertussis, correlates of protection have not been defined or accepted. We describe the clinical evaluation of DTPa- and DTPw-based combinations and demonstrate their immunological non-inferiority as compared to their separately administered licensed counterparts. With respect to antibody responses against pertussis, a number of evaluations (vaccine response rates and geometric mean concentrations (GMCs) for anti-PT, anti-FHA, anti-PRN or anti-BPT; reverse cumulative distribution curves) are described. We also demonstrate that the B. pertussis mouse lung clearance model is able to predict clinical efficacy of licensed DTPa and DTPw vaccines and represents a useful tool to evaluate new combination vaccines. (C) 2004 Elsevier GmbH. All rights reserved.

引用

页码：269 / 276

页数：8

共 17 条

[1] Intranasal murine model of Bordetella pertussis infection:: II.: Sequence variation and protection induced by a tricomponent acellular vaccine [J].

Boursaux-Eude, C ;

Thiberge, S ;

Carletti, G ;

Guiso, N .

VACCINE, 1999, 17 (20-21) :2651-2660

[2] A search for serologic correlates of immunity to Bordetella pertussis cough illnesses [J].

Cherry, JD ;

Gornbein, J ;

Heininger, U ;

Stehr, K .

VACCINE, 1998, 16 (20) :1901-1906

[3]

Corbel M J, 2004, Vaccine, V22, P293, DOI 10.1016/j.vaccine.2003.08.016

[4] Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection [J].

Denoël, P ;

Poolman, J ;

Carletti, G ;

Veitch, K .

VACCINE, 2002, 20 (19-20) :2551-2555

[5]

EDWARDS KM, 1995, PEDIATRICS, V96, P548

[6] A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis [J].

Greco, D ;

Salmaso, S ;

Mastrantonio, P ;

Giuliano, M ;

Tozzi, AE ;

Anemona, A ;

Atti, MLCD ;

Giammanco, A ;

Panei, P ;

Blackwelder, WC ;

Klein, DL ;

Wassilak, SGF ;

Stefanelli, P ;

Bottone, M ;

Sofia, T ;

Luzi, S ;

Bellomi, G ;

Cobianchi, F ;

Canganella, G ;

Meduri, F ;

Scuderi, G ;

Chiarini, A ;

Maggio, M ;

Taormina, S ;

Genovese, M ;

Moiraghi, A ;

Barale, A ;

DiTommaso, S ;

Malaspina, S ;

Vasile, E ;

Ferraro, P ;

DalLago, P ;

DeMarzi, L ;

Robino, L ;

Giraldo, E ;

Coppola, N ;

Materassi, P ;

Castellani, GT ;

Basso, F ;

Barbuti, S ;

Quarto, M ;

Lopalco, P ;

DOrazio, P ;

Sanguedolce, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :341-348

[7] Intranasal murine model of Bordetella pertussis infection.: I.: Prediction of protection in human infants by acellular vaccines [J].

Guiso, N ;

Capiau, C ;

Carletti, G ;

Poolman, J ;

Hauser, P .

VACCINE, 1999, 17 (19) :2366-2376

[8] A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine [J].

Gustafsson, L ;

Hallander, HO ;

Olin, P ;

Reizenstein, E ;

Storsaeter, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (06) :349-355

[9] Analysis of studies to evaluate immune response to combination vaccines [J].

Horne, AD ;

Lachenbruch, PA ;

Getson, PR ;

Hsu, HS .

CLINICAL INFECTIOUS DISEASES, 2001, 33 :S306-S311

[10] A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis [J].

Mills, KHG ;

Ryan, M ;

Ryan, E ;

Mahon, BP .

INFECTION AND IMMUNITY, 1998, 66 (02) :594-602

← 1 2 →